These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22011410)

  • 1. Serum level of endogenous secretory receptor for advanced glycation end products and other factors in type 2 diabetic patients with mild cognitive impairment.
    Chen G; Cai L; Chen B; Liang J; Lin F; Li L; Lin L; Yao J; Wen J; Huang H
    Diabetes Care; 2011 Dec; 34(12):2586-90. PubMed ID: 22011410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between serum endogenous secretory receptor for advanced glycation end products and risk of type 2 diabetes mellitus with combined depression in the Chinese population.
    Chen G; Wu Y; Wang T; Liang J; Lin W; Li L; Wen J; Lin L; Huang H
    Diabetes Technol Ther; 2012 Oct; 14(10):936-42. PubMed ID: 22856651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between endogenous secretory receptor for advanced glycation-end products (esRAGE) and carotid intima-media thickness in type 2 diabetes.
    Lin X; Chen X; Ye J; Li Q; Zhou J; Wu X; Huang Y; Li X; Shi Y; Li S; Li L; Cai H
    Exp Clin Endocrinol Diabetes; 2014 May; 122(5):277-80. PubMed ID: 24839222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased endogenous secretory advanced glycation end product receptor in type 1 diabetic patients: its possible association with diabetic vascular complications.
    Katakami N; Matsuhisa M; Kaneto H; Matsuoka TA; Sakamoto K; Nakatani Y; Ohtoshi K; Hayaishi-Okano R; Kosugi K; Hori M; Yamasaki Y
    Diabetes Care; 2005 Nov; 28(11):2716-21. PubMed ID: 16249545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased serum endogenous secretory receptor for advanced glycation end-product (esRAGE) levels in type 2 diabetic patients with decreased renal function.
    Gohda T; Tanimoto M; Moon JY; Gotoh H; Aoki T; Matsumoto M; Shibata T; Ohsawa I; Funabiki K; Tomino Y
    Diabetes Res Clin Pract; 2008 Aug; 81(2):196-201. PubMed ID: 18550199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between Ankle Brachial Index, Brachial-Ankle Pulse Wave Velocity, and Mild Cognitive Impairment in Patients with Acute Lacunar Infarction.
    Huang J; Tang J; Zhang Y; Zhang J; Tan Z; Shi S
    Eur Neurol; 2020; 83(2):147-153. PubMed ID: 32570253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased level of endogenous secretory receptor for advanced glycation end-products in diabetes with concomitant hyperlipidemia.
    Turk Z; Ljubić S; Boras J
    Physiol Res; 2014; 63(2):199-205. PubMed ID: 24397807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High intake of dietary advanced glycation end-products is associated with increased arterial stiffness and inflammation in subjects with type 2 diabetes.
    Di Pino A; Currenti W; Urbano F; Scicali R; Piro S; Purrello F; Rabuazzo AM
    Nutr Metab Cardiovasc Dis; 2017 Nov; 27(11):978-984. PubMed ID: 28958695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum advanced glycation end-products and receptors as prognostic biomarkers in diabetics undergoing coronary artery stent implantation.
    Shen Y; Pu LJ; Lu L; Zhang Q; Zhang RY; Shen WF
    Can J Cardiol; 2012; 28(6):737-43. PubMed ID: 23073352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visfatin and endogenous secretory receptor for advanced glycation end-products in diabetic type 2 and non-diabetic patients undergoing intermittent hemodialysis.
    Niepolski L; Grzegorzewska AE; Młot-Michalska M
    Int Urol Nephrol; 2010 Jun; 42(2):441-52. PubMed ID: 19184512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low serum level of the endogenous secretory receptor for advanced glycation end products (esRAGE) is a risk factor for prevalent vertebral fractures independent of bone mineral density in patients with type 2 diabetes.
    Yamamoto M; Yamaguchi T; Yamauchi M; Sugimoto T
    Diabetes Care; 2009 Dec; 32(12):2263-8. PubMed ID: 19752174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma Phospholipids are Associated with Mild Cognitive Impairment in Type 2 Diabetic Patients.
    Zhang JB; Cong YN; Li ZG; Sun HR; Zhang JS; Wang PF; Wu QZ
    Curr Alzheimer Res; 2017; 14(6):592-597. PubMed ID: 27915992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two soluble isoforms of receptors for advanced glycation end products (RAGE) in carotid atherosclerosis: the difference of soluble and endogenous secretory RAGE.
    Moriya S; Yamazaki M; Murakami H; Maruyama K; Uchiyama S
    J Stroke Cerebrovasc Dis; 2014; 23(10):2540-2546. PubMed ID: 25282185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between endogenous secretory RAGE, inflammatory markers and arterial stiffness.
    Choi KM; Yoo HJ; Kim HY; Lee KW; Seo JA; Kim SG; Kim NH; Choi DS; Baik SH
    Int J Cardiol; 2009 Feb; 132(1):96-101. PubMed ID: 18190981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low Endogenous Secretory Receptor for Advanced Glycation End-Products Levels Are Associated With Inflammation and Carotid Atherosclerosis in Prediabetes.
    Di Pino A; Urbano F; Zagami RM; Filippello A; Di Mauro S; Piro S; Purrello F; Rabuazzo AM
    J Clin Endocrinol Metab; 2016 Apr; 101(4):1701-9. PubMed ID: 26885882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased glycated albumin and decreased esRAGE levels are related to angiographic severity and extent of coronary artery disease in patients with type 2 diabetes.
    Lu L; Pu LJ; Zhang Q; Wang LJ; Kang S; Zhang RY; Chen QJ; Wang JG; De Caterina R; Shen WF
    Atherosclerosis; 2009 Oct; 206(2):540-5. PubMed ID: 19368923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1 h Postload Glycemia Is Associated with Low Endogenous Secretory Receptor for Advanced Glycation End Product Levels and Early Markers of Cardiovascular Disease.
    Di Pino A; Urbano F; Scicali R; Di Mauro S; Filippello A; Scamporrino A; Piro S; Purrello F; Rabuazzo AM
    Cells; 2019 Aug; 8(8):. PubMed ID: 31426413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-Reactive Protein, Advanced Glycation End Products, and Their Receptor in Type 2 Diabetic, Elderly Patients with Mild Cognitive Impairment.
    Gorska-Ciebiada M; Saryusz-Wolska M; Borkowska A; Ciebiada M; Loba J
    Front Aging Neurosci; 2015; 7():209. PubMed ID: 26578953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased serum myeloid-related protein 8/14 level is associated with atherosclerosis in type 2 diabetic patients.
    Peng WH; Jian WX; Li HL; Hou L; Wei YD; Li WM; Xu YW
    Cardiovasc Diabetol; 2011 May; 10():41. PubMed ID: 21592353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors of mild cognitive impairment in middle aged patients with type 2 diabetes: a cross-section study.
    Chen RH; Jiang XZ; Zhao XH; Qin YL; Gu Z; Gu PL; Zhou B; Zhu ZH; Xu LY; Zou YF
    Ann Endocrinol (Paris); 2012 Jun; 73(3):208-12. PubMed ID: 22704263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.